Literature DB >> 22027487

A molecular dynamics study of loop fluctuation in human papillomavirus type 16 virus-like particles: a possible indicator of immunogenicity.

Harshad Joshi1, Srinath Cheluvaraja, Endre Somogyi, Darron R Brown, Peter Ortoleva.   

Abstract

Immunogenicity varies between the human papillomavirus (HPV) L1 monomer assemblies of various sizes (e.g., monomers, pentamers or whole capsids). The hypothesis that this can be attributed to the intensity of fluctuations of important loops containing neutralizing epitopes for the various assemblies is proposed for HPV L1 assemblies. Molecular dynamics simulations were utilized to begin testing this hypothesis. Fluctuations of loops that contain critical neutralizing epitopes (especially FG loop) were quantified via root-mean-square fluctuation and features in the frequency spectrum of dynamic changes in loop conformation. If this fluctuation-immunogenicity hypothesis is a universal aspect of immunogenicity (i.e., immune system recognition of an epitope within a loop is more reliable when it is presented via a more stable delivery structure), then fluctuation measures can serve as one predictor of immunogenicity as part of a computer-aided vaccine design strategy.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22027487     DOI: 10.1016/j.vaccine.2011.10.039

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.

Authors:  Xiao Zhang; Lu Xin; Shaowei Li; Mujin Fang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Modeling Viral Capsid Assembly.

Authors:  Michael F Hagan
Journal:  Adv Chem Phys       Date:  2014       Impact factor: 1.000

3.  Variational methods for time-dependent classical many-particle systems.

Authors:  Yuriy V Sereda; Peter J Ortoleva
Journal:  Physica A       Date:  2013-02-15       Impact factor: 3.263

Review 4.  Engineering virus-like particles as vaccine platforms.

Authors:  Kathryn M Frietze; David S Peabody; Bryce Chackerian
Journal:  Curr Opin Virol       Date:  2016-03-29       Impact factor: 7.090

Review 5.  Multiscale Modeling in the Clinic: Drug Design and Development.

Authors:  Colleen E Clancy; Gary An; William R Cannon; Yaling Liu; Elebeoba E May; Peter Ortoleva; Aleksander S Popel; James P Sluka; Jing Su; Paolo Vicini; Xiaobo Zhou; David M Eckmann
Journal:  Ann Biomed Eng       Date:  2016-02-17       Impact factor: 3.934

6.  Computational Design of a Multi-Epitope Vaccine Against Porphyromonas gingivalis.

Authors:  Bilal Shaker; Sajjad Ahmad; Junhao Shen; Hyung Wook Kim; Dokyun Na
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.